What's New
Resources
Search Document
![]() |
New Drugs/Drug News
New drug reviews and evaluations; FAQs on drug-related topics; drug product comparisons
|
|
New Drugs/Drug News 2010 No. 4 (Jul/Aug)
First-in-class drug approval: Liraglutide (Victoza - Novo Nordisk Canada Inc.) for type 2 diabetes |
$10.50
Per Download |
|
New Drugs/Drug News 2010 No. 3 (May/Jun)
New antiplatelet agent: Prasugrel (Effient - Eli Lilly Canada Inc.) |
$10.50
Per Download |
|
New Drugs/Drug News 2010 No. 2 (Mar/Apr)
New antibiotic for complicated skin and skin structure infrections: Telavancin (Vibativ - Astellas Pharma Canada, Inc.) |
$10.50
Per Download |
|
New Drugs/Drug News 2010 No. 1 (Jan/Feb)
Clinical Update: Dyslipidemia and Prevention of Cardiovascular Disease |
$10.50
Per Download |
|
New Drugs/Drug News 2009 No. 5 (Sep/Oct)
Lapatinib ditosylate (Tykerb - GlaxoSmithKline Inc.) for advanced or metastatic breast cancer |
$10.50
Per Download |
|
New Drugs/Drug News 2009 No. 4 (Jul/Aug)
New Aldosterone receptor antagonist Eplerenone (Inspra - Pfizer Canada Inc.) |
$10.50
Per Download |
|
New Drugs/Drug News 2009 No. 3 (May/Jun)
New option for major depressive disorder: Desvenlafaxine (Pristiq - Wyeth Canada) |
$10.50
Per Download |
|
New Drugs/Drug News 2009 No. 2 (Mar/Apr)
Clinical Update on Antipsychotic Medications For Schizophrenia: Focus on Meta-Analyses |
$10.50
Per Download |
|
New Drugs/Drug News 2009 No. 1 (Jan/Feb)
New Vaccine for Herpes Zoster Prevention: Varicella Zoster Virus Vaccine, Live Attenuated (Zostavax) |
$10.50
Per Download |




